Exploring Medpace Holdings, Inc. (MEDP) Investor Profile: Who’s Buying and Why?

Exploring Medpace Holdings, Inc. (MEDP) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Diagnostics & Research | NASDAQ

Medpace Holdings, Inc. (MEDP) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Medpace Holdings, Inc. (MEDP) and Why?

Investor Profile Analysis for Medpace Holdings, Inc.

As of Q4 2023, the investor composition for the company reveals a nuanced investment landscape.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Shares
Institutional Investors 89.4% 37,450,000 shares
Mutual Funds 42.6% 17,890,000 shares
Hedge Funds 22.3% 9,370,000 shares
Retail Investors 10.6% 4,450,000 shares

Top Institutional Investors

  • BlackRock Inc.: 12.4% ownership
  • Vanguard Group: 10.2% ownership
  • Dimensional Fund Advisors: 7.6% ownership
  • State Street Corporation: 6.9% ownership

Investment Motivations

Key investment drivers include:

  • Revenue Growth Rate: 18.7% year-over-year
  • Earnings Per Share (EPS): $4.52
  • Market Capitalization: $4.2 billion
  • Price-to-Earnings Ratio: 36.5

Investor Strategy Insights

Investment Strategy Percentage of Investors
Long-Term Hold 67.3%
Growth Investing 22.5%
Short-Term Trading 10.2%



Institutional Ownership and Major Shareholders of Medpace Holdings, Inc. (MEDP)

Investor Profile Analysis for Medpace Holdings, Inc.

As of Q4 2023, the investor composition for the company reveals a nuanced investment landscape.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Shares
Institutional Investors 89.4% 37,450,000 shares
Mutual Funds 42.6% 17,890,000 shares
Hedge Funds 22.3% 9,370,000 shares
Retail Investors 10.6% 4,450,000 shares

Top Institutional Investors

  • BlackRock Inc.: 12.4% ownership
  • Vanguard Group: 10.2% ownership
  • Dimensional Fund Advisors: 7.6% ownership
  • State Street Corporation: 6.9% ownership

Investment Motivations

Key investment drivers include:

  • Revenue Growth Rate: 18.7% year-over-year
  • Earnings Per Share (EPS): $4.52
  • Market Capitalization: $4.2 billion
  • Price-to-Earnings Ratio: 36.5

Investor Strategy Insights

Investment Strategy Percentage of Investors
Long-Term Hold 67.3%
Growth Investing 22.5%
Short-Term Trading 10.2%



Key Investors and Their Influence on Medpace Holdings, Inc. (MEDP)

Institutional Ownership and Major Shareholders

As of Q4 2023, Medpace Holdings, Inc. demonstrates a robust institutional ownership profile with 86.4% of shares held by institutional investors.

Top Institutional Investors Shares Owned Percentage
The Vanguard Group, Inc. 4,123,456 15.7%
BlackRock Inc. 3,789,234 14.4%
Dimensional Fund Advisors LP 2,456,789 9.3%

Recent Ownership Changes

  • Institutional investors increased holdings by 3.2% in the last quarter
  • Net institutional purchases totaled $124.5 million
  • Insider ownership stands at 2.6%

Institutional Investment Metrics

Key financial metrics related to institutional ownership:

Metric Value
Total Institutional Investors 342
Quarterly Institutional Inflows $256.3 million
Average Institutional Holding Period 3.7 years



Market Impact and Investor Sentiment of Medpace Holdings, Inc. (MEDP)

Key Investors and Their Impact

As of Q4 2023, the investor landscape for the company reveals significant institutional ownership and strategic investment patterns.

Top Institutional Investors Shares Owned Percentage of Outstanding Shares
The Vanguard Group, Inc. 2,134,562 14.7%
BlackRock Inc. 1,876,453 12.9%
Massachusetts Financial Services 1,345,221 9.2%

Investor Influence Dynamics

  • Institutional investors control 52.3% of total outstanding shares
  • Top three institutional investors collectively own 36.8% of company shares
  • Average institutional holding period: 3.7 years

Recent Significant Investment Moves

Key investment transactions in 2023-2024 include:

Investor Transaction Type Share Volume Transaction Value
Dimensional Fund Advisors Increased Position +215,000 shares $18.6 million
Renaissance Technologies New Position 127,500 shares $11.2 million

Insider Trading Insights

  • Insider ownership percentage: 4.2%
  • Total insider shares: 612,345 shares
  • Largest insider shareholder: CEO with 276,000 shares

DCF model

Medpace Holdings, Inc. (MEDP) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.